ConductScience.org, home

Paper28673296

Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009.

Hartmann-Johnsen OJ and 3 others. World J Surg Oncol, 2017. Cited by 31 papers, by iCite.

Cite this record

ConductScience Library. Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009. Papers, record 28673296. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28673296

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009.
PubMed
Journal
World J Surg Oncol
PubMed
Year
2017
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
1.16
iCite
Revised in PubMed
2022-04-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hartmann-Johnsen OJOlaf Johan
2Kåresen RRolf
3Schlichting EEllen
4Nygård JFJan F

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
MastectomyMajor topic
Mastectomy, SegmentalMajor topic
RegistriesMajor topic
Aged
Axilla
Female
Follow-Up Studies
Humans
Middle Aged
Prognosis
Survival Rate

Source PubMed

Download CSV of topics

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122373563Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial.Lancet Oncol2012https://conductscience.org/library/papers/22373563PubMed
222113254Twenty-five year results of the national cancer institute randomized breast conservation trial.Breast Cancer Res Treat2012https://conductscience.org/library/papers/22113254PubMed
327306422The recurrence pattern following delayed breast reconstruction after mastectomy for breast cancer suggests a systemic effect of surgery on occult dormant micrometastases.Breast Cancer Res Treat2016https://conductscience.org/library/papers/27306422PubMed
424429935Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer.JAMA Surg2014https://conductscience.org/library/papers/24429935PubMed
519114703Can women with early-stage breast cancer make an informed decision for mastectomy?J Clin Oncol2009https://conductscience.org/library/papers/19114703PubMed
616360786Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.Lancet2005https://conductscience.org/library/papers/16360786PubMed
723359049Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status.Cancer2013https://conductscience.org/library/papers/23359049PubMed
815161695Cellular immunity in breast cancer patients completing taxane treatment.Clin Cancer Res2004https://conductscience.org/library/papers/15161695PubMed
925076293Histologic grade remains a prognostic factor for breast cancer regardless of the number of positive lymph nodes and tumor size: a study of 161 708 cases of breast cancer from the SEER Program.Arch Pathol Lab Med2014https://conductscience.org/library/papers/25076293PubMed
1026517676Comparative effectiveness study of breast-conserving surgery and mastectomy in the general population: A NCDB analysis.Oncotarget2015https://conductscience.org/library/papers/26517676PubMed
1121559024Why do hospital mastectomy rates vary? Differences in the decision-making experiences of women with breast cancer.Br J Cancer2011https://conductscience.org/library/papers/21559024PubMed
1222523340The prognostic significance of early stage lymph node positivity in operable invasive breast carcinoma: number or stage.J Clin Pathol2012https://conductscience.org/library/papers/22523340PubMed
1325315501Small breast cancers: when and how to treat.Cancer Treat Rev2014https://conductscience.org/library/papers/25315501PubMed
142804892The influence of surgical trauma on experimental metastasis.Cancer1989https://conductscience.org/library/papers/2804892PubMed
1522644510Twenty-year outcomes after breast-conserving surgery and definitive radiotherapy for mammographically detected ductal carcinoma in situ.Ann Surg Oncol2012https://conductscience.org/library/papers/22644510PubMed
169472641Stimulation of tumour angiogenesis by proximal wounds: spatial and temporal analysis by MRI.Br J Cancer1998https://conductscience.org/library/papers/9472641PubMed
1712393820Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.N Engl J Med2002https://conductscience.org/library/papers/12393820PubMed
1823265570Prognostic significance of the number of positive lymph nodes in women with T1-2N1 breast cancer treated with mastectomy: should patients with 1, 2, and 3 positive lymph nodes be grouped together?Int J Radiat Oncol Biol Phys2013https://conductscience.org/library/papers/23265570PubMed
1911745450Interval cancers in the Norwegian breast cancer screening program: frequency, characteristics and use of HRT.Int J Cancer2001https://conductscience.org/library/papers/11745450PubMed
2021646474Pivotal role of innate and adaptive immunity in anthracycline chemotherapy of established tumors.Cancer Res2011https://conductscience.org/library/papers/21646474PubMed

See all 30 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
40103401Survival after standard or oncoplastic breast-conserving surgery versus mastectomy for breast cancer.BJS Open2025https://conductscience.org/library/papers/40103401PubMed
39328281Higher 10-Year Survival with Breast-Conserving Therapy over Mastectomy for Women with Early-Stage (I-II) Breast Cancer: Analysis of the CDC Patterns of Care Data Base.Breast Cancer (Auckl)2024https://conductscience.org/library/papers/39328281PubMed
38758563Overall survival after mastectomy versus breast-conserving surgery with adjuvant radiotherapy for early-stage breast cancer: meta-analysis.BJS Open2024https://conductscience.org/library/papers/38758563PubMed
38717543"Peace of Mind" After Mastectomy: A Scoping Review.Ann Surg Oncol2024https://conductscience.org/library/papers/38717543PubMed
37600290Breast-Conserving Surgery or Mastectomy?: Impact on Survival.Ann Surg Open2022https://conductscience.org/library/papers/37600290PubMed
37358683
Breast-Conserving Therapy is Associated with Improved Survival Without an Increased Risk of Locoregional Recurrence Compared with Mastectomy in Both Clinically Node-Positive and Node-Negative Breast Cancer Patients.
Ann Surg Oncol2023https://conductscience.org/library/papers/37358683PubMed
37200923The unifying concepts of the sick lobe hypothesis, field cancerisation and breast conservation treatment for multiple ipsilateral breast cancers: a narrative review.Gland Surg2023https://conductscience.org/library/papers/37200923PubMed
37052762Racial/ethnic and socioeconomic differences in breast cancer surgery performed and delayed treatment: mediating impact on mortality.Breast Cancer Res Treat2023https://conductscience.org/library/papers/37052762PubMed
36618070Postoperative Radiotherapy Contributes to the Survival Benefit of Breast-Conserving Therapy over Mastectomy.J Oncol2022https://conductscience.org/library/papers/36618070PubMed
35459407Effect of Local Versus General Anesthesia in Breast-Conserving Surgery on Cancer Recurrence and Cost.Cancer Control2022https://conductscience.org/library/papers/35459407PubMed
35212160Breast-conserving therapy is associated with better survival than mastectomy in Early-stage breast cancer: A propensity score analysis.Cancer Med2022https://conductscience.org/library/papers/35212160PubMed
34677259
Multifocality and Multicentrality in Breast Cancer: Comparison of the Efficiency of Mammography, Contrast-Enhanced Spectral Mammography, and Magnetic Resonance Imaging in a Group of Patients with Primarily Operable Breast Cancer.
Curr Oncol2021https://conductscience.org/library/papers/34677259PubMed
34439197Improved Survival after Breast-Conserving Therapy Compared with Mastectomy in Stage I-IIA Breast Cancer.Cancers (Basel)2021https://conductscience.org/library/papers/34439197PubMed
33049657Breast-conserving surgery with or without irradiation in women with invasive ductal carcinoma of the breast receiving preoperative systemic therapy: A cohort study.Breast2020https://conductscience.org/library/papers/33049657PubMed
32181017Saving the Breast Saves the Lives of Breast Cancer Patients.Int J Surg Oncol2020https://conductscience.org/library/papers/32181017PubMed
31632048Investigation of Prognostic Factors of Survival in Breast Cancer Using a Frailty Model: A Multicenter Study.Breast Cancer (Auckl)2019https://conductscience.org/library/papers/31632048PubMed
31372049Comparison of long-term results between radiotherapy after breast-conserving surgery and postmastectomy radiotherapy in stage T1-2N1M0 breast cancer.Cancer Manag Res2019https://conductscience.org/library/papers/31372049PubMed
2921861418F-fluorodeoxyglucose specimen-positron emission mammography delineates tumour extension in breast-conserving surgery: Preliminary results.Eur Radiol2018https://conductscience.org/library/papers/29218614PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
NR4A13164PubTator's text mininghttps://conductscience.org/library/genes/3164NCBI Gene
TENM110178PubTator's text mininghttps://conductscience.org/library/genes/10178NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28673296

GET https://conductscience.org/api/papers/v1/28673296/references?page=2